Название продукции:3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid

IUPAC Name:3-methyl-5H,6H,7H,8H-[1,3]thiazolo[3,2-a][1,3]diazepine-2-carboxylic acid

CAS:876716-40-4
Молекулярная формула:C9H12N2O2S
Чистота:95%
Номер в каталоге:CM527116
Молекулярная масса:212.27

Упаковочная единица Доступно для заказа Цена ($) Количество
CM527116-1g in stock Ÿǫdž

Только для использования в НИОКР..

Форма запроса

   refresh    

Информация о продукции

Номер CAS:876716-40-4
Молекулярная формула:C9H12N2O2S
Точка плавления:-
Smiles-код:O=C(C(S1)=C(C)N2C1=NCCCC2)O
Плотность:
Номер в каталоге:CM527116
Молекулярная масса:212.27
Точка кипения:
Номер Mdl:MFCD07186416
Хранение:

Category Infos

Thiazolines
Thiazolines are a group of isomeric five-membered heterocyclic compounds containing both sulfur and nitrogen. Thiazoline exists in three isomeric forms namely 2-thiazoline, 3-thiazoline and 4-thiazoline. Oxazolines, oxazoles, thiazolines, and thiazoles form the characteristic heterocyclic building blocks of lissoclinum peptide alkaloids.

Related Products



Product Other Information

Product Overview 3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid, also known as 3MTD, is an organic compound with a molecular formula of C9H10N2O2S. It is a member of the thiazolodiazepine family, which is a class of compounds characterized by a thiazole ring fused to a diazepine ring. 3MTD has a wide range of biological activities, including anticonvulsant, anti-inflammatory, and anti-epileptic effects. It has been studied for its potential therapeutic applications in the treatment of epilepsy, depression, anxiety, and other neurological disorders.
Synthesis and Application 3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid can be synthesized through a multi-step process involving the reaction of 2-amino-3,3-dimethylbutan-1-ol with ethyl chloroformate, followed by reaction with thiourea and subsequent hydrolysis. The reaction is carried out in a solvent such as ethanol or dimethylformamide. The yield of the reaction is typically around 70%. 3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid has been studied for its potential therapeutic applications in the treatment of epilepsy, depression, anxiety, and other neurological disorders. In animal studies, 3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid has been found to possess anticonvulsant and anti-epileptic effects, as well as anti-inflammatory and neuroprotective effects. It has also been shown to reduce the severity of seizures in mice and rats.
Future Directions The potential therapeutic applications of 3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid are still being explored. Future research could focus on the development of new formulations of 3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid that have improved pharmacokinetic and pharmacodynamic profiles. Additionally, further studies could be conducted to evaluate the efficacy and safety of 3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid in clinical trials. Other potential areas of research include the development of new methods for synthesizing 3-Methyl-5,6,7,8-tetrahydro-thiazolo[3,2-a][1,3]-diazepine-2-carboxylic acid, as well as the exploration of its potential uses in the treatment of other neurological disorders.